A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients

Aim: To evaluate the efficacy of topical aldose reductase inhibitor CT-112 (5-[3-ethoxy-4-pentyloxyphenyl]-2,4-thiazolidinedione) on corneal epithelial barrier function in diabetic patients. Methods: This was a prospective, randomised, double masked placebo controlled study. 34 eyes of 34 diabetic p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nakahara, M, Miyata, K, Otani, S, Miyai, T, Nejima, R, Yamagami, S, Amano, S
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2005 British Journal of Ophthalmology 2005
Assuntos:
Clinical Science - Scientific Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1772556/
https://ncbi.nlm.nih.gov/pubmed/15722300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2004.049841
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados